Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XEN-D0501 for cough reduction in COPD patients
2013-004041-17Phase 2Completed
- Sponsor
- Xention Ltd.
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing XEN-D0501 sequence with Placebo sequence (2 arms). Started Nov 2013; status: completed.
02
Drugs
XEN-D0501
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2013-004041-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004041-17.